UBS maintains a 'Neutral' on Seattle Genetics (Nasdaq: SGEN), lowers PT by $0.50 to $12.50.

UBS analyst says, "While a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE